An investigational oral drug called sebetralstat was found to provide on-demand relief for attacks of tissue swelling in patients with hereditary angioedema, according to a Phase 3 study. The study showed promising results in reducing symptoms of the condition. The drug may offer a new treatment option for patients experiencing these attacks. Cookies are used on the website for analytics, advertising, and site improvement purposes. By continuing to use the site, users agree to the use of cookies. More information on cookies can be found in the Cookie Policy and Cookie Settings on the website.
Source link
Investigational oral drug sebetralstat provided on-demand relief during tissue swelling attacks from hereditary angioedema: Phase 3 study
